Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BTCY NASDAQ:ICU NASDAQ:IRIX NASDAQ:PTHL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTCYBiotricity$0.62-12.7%$0.59$0.21▼$0.83$16.57M1.1238,051 shs96,894 shsICUSeaStar Medical$0.63-1.0%$0.79$0.31▼$4.28$21.71M-1.074.02 million shs3.32 million shsIRIXIRIDEX$1.05-0.9%$1.22$0.78▼$1.95$18.01M0.5971,430 shs67,117 shsPTHLPheton$0.61-11.8%$0.77$0.51▼$32.00$4.51MN/A118,873 shs191,195 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTCYBiotricity-12.68%-7.46%-7.60%+42.46%+181.82%ICUSeaStar Medical-1.02%+4.41%-28.79%-11.20%-85.00%IRIXIRIDEX-0.94%-6.25%-17.97%-16.67%-33.96%PTHLPheton-11.77%-17.12%-32.78%-97.28%-87.88%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTCYBiotricity$0.62-12.7%$0.59$0.21▼$0.83$16.57M1.1238,051 shs96,894 shsICUSeaStar Medical$0.63-1.0%$0.79$0.31▼$4.28$21.71M-1.074.02 million shs3.32 million shsIRIXIRIDEX$1.05-0.9%$1.22$0.78▼$1.95$18.01M0.5971,430 shs67,117 shsPTHLPheton$0.61-11.8%$0.77$0.51▼$32.00$4.51MN/A118,873 shs191,195 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTCYBiotricity-12.68%-7.46%-7.60%+42.46%+181.82%ICUSeaStar Medical-1.02%+4.41%-28.79%-11.20%-85.00%IRIXIRIDEX-0.94%-6.25%-17.97%-16.67%-33.96%PTHLPheton-11.77%-17.12%-32.78%-97.28%-87.88%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBTCYBiotricity 2.00HoldN/AN/AICUSeaStar Medical 1.00SellN/AN/AIRIXIRIDEX 1.00SellN/AN/APTHLPheton 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest PTHL, IRIX, BTCY, and ICU Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025ICUSeaStar MedicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)10/8/2025IRIXIRIDEXWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)10/8/2025PTHLPhetonWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025ICUSeaStar MedicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025IRIXIRIDEXWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/27/2025PTHLPhetonWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 10/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBTCYBiotricity$12.06M1.37N/AN/A($1.30) per share-0.48ICUSeaStar Medical$140K153.50N/AN/A($0.34) per share-1.85IRIXIRIDEX$48.67M0.37N/AN/A$0.13 per share8.08PTHLPheton$450K8.85N/AN/A$0.94 per share0.64Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBTCYBiotricity-$14.09M-$0.21N/A∞N/A-80.42%N/A-188.47%11/13/2025 (Estimated)ICUSeaStar Medical-$24.83M-$2.62N/A∞N/A-1,915.27%N/A-232.65%11/12/2025 (Estimated)IRIXIRIDEX-$8.91M-$0.33N/A∞N/A-10.95%-386.93%-17.42%11/11/2025 (Estimated)PTHLPheton-$660KN/A0.00∞N/AN/AN/AN/AN/ALatest PTHL, IRIX, BTCY, and ICU EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/13/2025N/ABTCYBiotricity-$0.08N/AN/AN/A$3.90 millionN/A8/13/2025Q2 2025ICUSeaStar Medical-$0.43-$0.18+$0.25-$0.18$0.25 million$0.34 million8/12/2025Q2 2025IRIXIRIDEX-$0.09-$0.06+$0.03-$0.06$13.10 million$13.57 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBTCYBiotricityN/AN/AN/AN/AN/AICUSeaStar MedicalN/AN/AN/AN/AN/AIRIXIRIDEXN/AN/AN/AN/AN/APTHLPhetonN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBTCYBiotricityN/A0.230.10ICUSeaStar MedicalN/A1.521.50IRIXIRIDEX62.291.961.34PTHLPhetonN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBTCYBiotricity3.89%ICUSeaStar Medical1.69%IRIXIRIDEX20.10%PTHLPhetonN/AInsider OwnershipCompanyInsider OwnershipBTCYBiotricity10.10%ICUSeaStar Medical1.30%IRIXIRIDEX7.40%PTHLPhetonN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBTCYBiotricity4026.73 million22.08 millionOptionableICUSeaStar Medical234.10 million27.55 millionNot OptionableIRIXIRIDEX12016.99 million15.74 millionOptionablePTHLPheton116.58 millionN/AN/APTHL, IRIX, BTCY, and ICU HeadlinesRecent News About These CompaniesPheton Holdings Enters Strategic Advisory Agreement with Comane InternationalSeptember 2, 2025 | tipranks.comPheton Holdings Acquires Stake in Geri-Safe to Boost Medical Device InnovationAugust 29, 2025 | tipranks.comPheton Holdings Acquires Majority Stake in iTonic CorporationAugust 29, 2025 | tipranks.comDeepfake of fund manager Anthony Bolton could savage your savings in 'pump and dump' shares scamAugust 18, 2025 | msn.comPenny stock selloffs fuel concerns over pump-and-dump scams - reportAugust 18, 2025 | msn.comPheton Holdings Addresses Market Volatility and RumorsAugust 6, 2025 | theglobeandmail.comPheton Holdings Ltd Addresses Market Volatility and Denies Acquisition RumorsAugust 1, 2025 | quiverquant.comQPheton Holdings Ltd Issues Statements Addressing Recent Market Activity and Misleading Rumors | ...August 1, 2025 | gurufocus.comPheton Holdings Ltd Issues Statements Addressing Recent Market Activity and Misleading RumorsAugust 1, 2025 | globenewswire.comPheton Holdings Ltd. Cl A (PTHL) Stock Price Today - WSJJuly 31, 2025 | wsj.comChinese Health Care Stock Pheton Holdings Collapses After Short Seller Warns Of Manipulation By 'Overseas Scammers'July 30, 2025 | benzinga.comPTHL: Trading Resumes for Pheton Holdings LtdJuly 29, 2025 | gurufocus.comPheton Holdings Ltd (PTHL) - Yahoo FinanceJune 28, 2025 | finance.yahoo.comPTHL Pheton Holdings Ltd - Seeking AlphaJune 27, 2025 | seekingalpha.comPheton Holdings Ltd Announces Closing of Initial Public OfferingSeptember 6, 2024 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePTHL, IRIX, BTCY, and ICU Company DescriptionsBiotricity NASDAQ:BTCY$0.62 -0.09 (-12.68%) As of 10/16/2025 03:39 PM EasternBiotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.SeaStar Medical NASDAQ:ICU$0.63 -0.01 (-1.02%) Closing price 10/16/2025 04:00 PM EasternExtended Trading$0.64 +0.01 (+1.40%) As of 10/16/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.IRIDEX NASDAQ:IRIX$1.04 -0.02 (-1.89%) As of 10/16/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.Pheton NASDAQ:PTHL$0.60 -0.08 (-11.77%) Closing price 10/16/2025 03:59 PM EasternExtended Trading$0.61 +0.01 (+1.16%) As of 10/16/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Archer Buys Rival's Patent Treasure Trove in Strategic Move Qualcomm: What Last Friday’s Drop Says About Its Q4 Prospects An AI Play Hiding in Plain Sight: A Look at Johnson Controls Walmart's AI Play: OpenAI Deal Forges a New Path to Profitability AppLovin Drops 14%: Should Investors Worry About SEC Probe? Advanced Micro Devices Eyes $300 as AI Demand Surges From Bulldozers to Big Data: Caterpillar’s Bull Case Gets a Lift Why Analysts Are Upgrading Ratings After Klarna's IPO Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
